Mylan Announces Conference Call to Provide a Strategic Business UpdatePITTSBURGH, June 7 /PRNewswire-FirstCall/ -- Mylan Laboratories Inc. (NYSE: MYL) announced today that it will host a conference call to provide financial guidance, a strategic business update and an update on nebivolol, its next-generation beta blocker on Tuesday, June 14, 2005 at 8:30 AM EDT.

Mylan will also kick off an investor roadshow beginning on Wednesday, June 15, 2005.

The presentation will be available live via webcast and conference call. To listen to the webcast and view the accompanying slide presentation, please go to Mylan's website at http://www.mylan.com and click on the webcast icon at least 15 minutes before the presentation is to begin to register and download or install any necessary audio software. If you are unable to listen to the live webcast, please access http://www.mylan.com at any time within seven days to listen to a replay of the webcast.

The audio presentation will also be available via teleconference, which can be accessed by dialing (800) 811-0667 or (913) 981-4901 for international callers. A replay will be available at (888) 203-1112, or (719) 457-0820 for international callers, using the conference ID code: 9489662.

About Mylan Laboratories:

Mylan Laboratories Inc. is a leading pharmaceutical company with four subsidiaries, Mylan Pharmaceuticals Inc., Mylan Technologies Inc., UDL Laboratories, Inc. and Mylan Bertek Pharmaceuticals Inc., that develop, license, manufacture, market and distribute an extensive line of generic and proprietary products.

For more information about Mylan, visit www.mylan.com .

SOURCE Mylan Laboratories Inc.
06/07/2005
CONTACT: Media, Patrick Fitzgerald, +1-724-514-1800, or Investors, Kris King, +1-724-514-1800, both of Mylan Laboratories Inc.
Web site: http://www.mylan.com